IV Ibuprofen Market is Expected to Reach $14.2 Million,: New Technology, Application, Type, Customer Segments, and Top Key Players Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc. (Acquired by Teligent, Inc.), CSL Limited, Sandor Medicaids Pv

Intravenous (IV) Ibuprofen Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $14.2 million by 2022, registering a CAGR of 20.0% during the period 2016-2022. The pain indication segment accounted for over three-fourths share in 2015 and is expected to maintain its dominance throughout the forecast period.

The major factors that boost the market growth include, increase in adoption of an intravenous mode of drug delivery for acute pain management due to faster onset of action as compared to the other routes (oral and transdermal mode of administration) and targeted drug delivery property. The market growth is further augmented as IV ibuprofen improves pain management with less dependence on opioid analgesic medication, which may lead to several health complications such as sedation, dizziness, and others. Caldolor (Cumberland Pharmaceuticals) is the only injectable ibuprofen drug available in the market; hence, it has huge demand with minimal competition. However, numerous factors are likely to restrain the market growth such as lengthy approval process and limited geographic (country specific) approvals

Buy now and get FREE One Month Knowledge Tree Subscription (valid till 30 Nov'18):
https://www.alliedmarketresearch.com/checkout/424936?utm_source=Prathm_OPR

The U.S. is anticipated to remain the highest revenue-generating region during the forecast period, owing to the widespread adoption of IV Ibuprofen for treating pain and fever. However, Australia is expected to grow rapidly during the forecast period, owing to recent entry of IV Ibuprofen in this market, increasing awareness of non-steroidal anti-inflammatory drugs, and shifting trend towards intravenous mode of drug delivery.

Key Findings of IV Ibuprofen Market:

• Fever is projected to be the fastest growing indication segment.

• Australia IV Ibuprofen market is expected to grow at the fastest CAGR of 14.7% from 2015 to 2020.

• In 2015, the U.S. and Canada collectively accounted for more than three-fourths of the global IV Ibuprofen market.

Get sample copy of this report :
https://www.alliedmarketresearch.com/request-sample/1387?utm_source=Prathm_OPR

Top Key players in the market:
• Cumberland Pharmaceuticals Inc.
• Alveda Pharmaceuticals Inc.
• (Acquired by Teligent Inc.)
• CSL Limited
• Sandor Medicaids Pvt. Ltd.
• PT. Soho Industri Pharmasi
• Germin MED
• Grifols S.A.
• Harbin Gloria Pharmaceuticals Co.Ltd.
• Al Nabeel International Ltd.
• Laboratorios Valmorca

Table of content :


Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models


Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2027

2.2.1 Moderate scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario


Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis
3.4 Government regulations
3.5 Research & Analysis

3.5.1 Clinical trials

3.6 Market dynamics

3.6.1 Drivers
3.6.2 Restraints
3.6.3 Opportunities


Chapter: 4 WORLD INTRAVENOUS IBUPROFENMARKET, BY AGE GROUP, 2015-2022

4.1 Pediatrics

4.1.1 Market size and forecast

4.2 Adults

4.2.1 Market size and forecast

List of Table

TABLE 1 WORLD IV IBUPROFEN MARKET, MODERATE SCENARIO, BY COUNTRY, 2022 2027 ($MILLION)
TABLE 2 WORLD IV IBUPROFEN MARKET, RAPID GROWTH SCENARIO, BY COUNTRY, 2022 2027 ($MILLION)
TABLE 3 WORLD IV IBUPROFEN MARKET, DIMINISHING GROWTH SCENARIO, BY COUNTRY, 2022 2027 ($MILLION)
TABLE 4 CLINICAL TRIALS - ANALGESICS
TABLE 5 GLOBAL INCIDENCES OF DISEASES
TABLE 6 WORLD IV IBUPROFEN MARKET BY AGE GROUP, 2015-2022 ($MILLION)
TABLE 7 WORLD PEDIATRIC IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 8 WORLD ADULT IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 9 WORLD PAIN IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 10 WORLD FEVER IV IBUPROFEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 11 WORLD IV IBUPROFEN MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 12 UNITED STATES: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 13 CANADA: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 14 AUSTRALIA: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 15 SOUTH KOREA: ACTUAL IV IBUPROFEN MARKET, 20152022 ($MILLION)
TABLE 16 COMPANY SNAPSHOT OF CUMBERLAND PHARMACEUTICALS
TABLE 17 CUMBERLAND PHARMACEUTICALS OPERATING SEGMENTS
TABLE 18 COMPANY SNAPSHOT OF ALVEDA PHARMACEUTICALS, INC.
TABLE 19 ALVEDA PHARMACEUTICALS, INC. OPERATING SEGMENTS
TABLE 20 COMPANY SNAPSHOT OF CSL LIMITED

Get Access to Full summary of this report at :
https://www.alliedmarketresearch.com/intravenous-ibuprofen-market?utm_source=Prathm_OPR

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.